These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 7840520

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prognostic factors and staging systems of multiple myeloma:
    Tao ZF, Fu WJ, Yuan ZG, Wang DX, Chen YB, Hou J.
    Chin Med J (Engl); 2007 Oct 05; 120(19):1655-8. PubMed ID: 17935664
    [Abstract] [Full Text] [Related]

  • 5. International staging system for multiple myeloma.
    Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, Bladé J, Boccadoro M, Child JA, Avet-Loiseau H, Kyle RA, Lahuerta JJ, Ludwig H, Morgan G, Powles R, Shimizu K, Shustik C, Sonneveld P, Tosi P, Turesson I, Westin J.
    J Clin Oncol; 2005 May 20; 23(15):3412-20. PubMed ID: 15809451
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?
    Baur A, Stäbler A, Nagel D, Lamerz R, Bartl R, Hiller E, Wendtner C, Bachner F, Reiser M.
    Cancer; 2002 Sep 15; 95(6):1334-45. PubMed ID: 12216103
    [Abstract] [Full Text] [Related]

  • 8. Extent of disease burden determined with magnetic resonance imaging of the bone marrow is predictive of survival outcome in patients with multiple myeloma.
    Ailawadhi S, Abdelhalim AN, Derby L, Mashtare TL, Miller KC, Wilding GE, Alberico RA, Gottlieb R, Klippenstein DL, Lee K, Chanan-Khan AA.
    Cancer; 2010 Jan 01; 116(1):84-92. PubMed ID: 19862816
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. International prognostic index (IPI)--a critical comparison with five multiple myeloma staging systems in the group of 270 patients treated by conventional chemotherapy.
    Scudla V, Zemanova M, Minarik J, Bacovsky J, Ordeltova M, Indrak K, Budikova M, Dusek L, Farbiakova V.
    Neoplasma; 2006 Jan 01; 53(4):277-84. PubMed ID: 16830053
    [Abstract] [Full Text] [Related]

  • 11. [Analysis of the international staging system of multiple myeloma and its comparison with the DS and IFM staging system in 122 Chinese patients].
    Deng SH, Xu Y, Mai YJ, Wang YF, Zhao YZ, Zou DH, Qiu LG.
    Zhonghua Xue Ye Xue Za Zhi; 2008 Apr 01; 29(4):217-21. PubMed ID: 18843972
    [Abstract] [Full Text] [Related]

  • 12. [Prognostic value of the ratio of bone marrow plasma cells in multiple myeloma].
    Pasqualetti P, Colantonio D, Casale R.
    Minerva Med; 1990 Mar 01; 81(3):129-33. PubMed ID: 2320280
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A comparison of two staging systems for myeloma.
    Vercelli D, Cozzolino F, Di Guglielmo R.
    Nouv Rev Fr Hematol (1978); 1981 Mar 01; 23(2):107-10. PubMed ID: 7290984
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [A comparison of staging classifications of plasmacytoma].
    Löffler H, Gassmann W, Haferlach T, Pralle H.
    Onkologie; 1986 Aug 01; 9(4):196, 199-201. PubMed ID: 3531946
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.